Form 4: Nurix Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Gwenn Hansen, Chief Scientific Officer of Nurix Therapeutics, Inc., sold 1,452 shares of common stock on September 1, 2026 for $25.47 per share.
Summary
- Option exercise/conversion: acquired 1,452 Common Stock at $1.86 ($2,701) on September 1, 2026; holds 118,679 after (Direct).
- Open-market sale: disposed of 1,452 Common Stock at $25.47 ($36,982) on September 1, 2026; holds 117,227 after (Direct).
- Option exercise/conversion: disposed of 1,452 Employee Stock Option (right to buy) on September 1, 2026; holds 60,858 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $36,982 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Gwenn Hansen — Officer (Chief Scientific Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Option exercise/conversion | Common Stock | 1,452 | $2 | $2.7K | 118,679 |
| 2026-09-01 | Open-market sale | Common Stock | 1,452 | $25 | $37.0K | 117,227 |
| 2026-09-01 | Option exercise/conversion | Employee Stock Option (right to buy) | 1,452 | — | — | 60,858 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Option exercise/conversion (1,452 shares) |
| 2026-09-01 | Open-market sale (1,452 shares) |
| 2026-09-01 | Option exercise/conversion (1,452 shares) |
Keywords
insider transaction, Form 4, NRIX, Nurix Therapeutics, Inc., bearish, Gwenn Hansen
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.